These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8396262)

  • 1. Physicochemical characterization of a ouabain isomer isolated from bovine hypothalamus.
    Tymiak AA; Norman JA; Bolgar M; DiDonato GC; Lee H; Parker WL; Lo LC; Berova N; Nakanishi K; Haber E
    Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8189-93. PubMed ID: 8396262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A non-ouabain Na/K ATPase inhibitor isolated from bovine hypothalamus. Its relation to hypothalamic ouabain.
    Sancho JM
    Clin Exp Hypertens; 1998; 20(5-6):535-42. PubMed ID: 9682909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of a ouabain-like factor from Milan hypertensive rats.
    Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S75-8. PubMed ID: 7508036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Na,K-ATPase inhibitors from bovine hypothalamus and human plasma are different from ouabain: nanogram scale CD structural analysis.
    Zhao N; Lo LC; Berova N; Nakanishi K; Tymiak AA; Ludens JH; Haupert GT
    Biochemistry; 1995 Aug; 34(31):9893-6. PubMed ID: 7632688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two biologically active isomers of dihydroouabain isolated from a commercial preparation.
    Qazzaz HM; El-Masri MA; Stolowich NJ; Valdes R
    Biochim Biophys Acta; 1999 Nov; 1472(3):486-97. PubMed ID: 10564763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the structure of endogenous ouabain.
    Kawamura A; Guo J; Itagaki Y; Bell C; Wang Y; Haupert GT; Magil S; Gallagher RT; Berova N; Nakanishi K
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6654-9. PubMed ID: 10359767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of the purified hypothalamic pituitary NA/K-ATPase inhibitor.
    Sancho JM; Garcia-Martin E; Garcia-Robles R; Santirso R; Villa E; Gutierrez-Merino C; Ricote M
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S32-4. PubMed ID: 7508022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous sodium pump inhibitors in human urine. Further identification of inhibitors of Na-K-ATPase.
    Kramer HJ; Krampitz G; Bäcker A; Michel H; Krampitz G; Meyer-Lehnert H
    Am J Hypertens; 1995 Jul; 8(7):753-60. PubMed ID: 7546503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass spectral characterization of an endogenous digitalislike factor from human plasma.
    Mathews WR; DuCharme DW; Hamlyn JM; Harris DW; Mandel F; Clark MA; Ludens JH
    Hypertension; 1991 Jun; 17(6 Pt 2):930-5. PubMed ID: 1646172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothalamic Na(+)-K(+)-ATPase inhibitor characterized in two-sided liposomes containing pure renal Na(+)-K(+)-ATPase.
    Anner BM; Rey HG; Moosmayer M; Meszoely I; Haupert GT
    Am J Physiol; 1990 Jan; 258(1 Pt 2):F144-53. PubMed ID: 2154124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Na+/K+-ATPase inhibitors in bovine plasma as fatty acids and hydrocarbons.
    Tal DM; Yanuck MD; van Hall G; Karlish SJ
    Biochim Biophys Acta; 1989 Oct; 985(1):55-9. PubMed ID: 2551389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia triggers release of an endogenous inhibitor of Na(+)-K(+)-ATPase from midbrain and adrenal.
    De Angelis C; Haupert GT
    Am J Physiol; 1998 Jan; 274(1):F182-8. PubMed ID: 9458838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bovine adrenocortical cells in culture synthesize an ouabain-like compound.
    Perrin A; Brasmes B; Chambaz EM; Defaye G
    Mol Cell Endocrinol; 1997 Jan; 126(1):7-15. PubMed ID: 9027358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothalamic Na+,K(+)-ATPase inhibitor constricts pulmonary arteries of spontaneously hypertensive rats.
    Janssens SP; Kachoris C; Parker WL; Hales CA; Haupert GT
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S42-6. PubMed ID: 7508026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothalamic sodium-transport inhibitor is a high-affinity reversible inhibitor of Na+-K+-ATPase.
    Haupert GT; Carilli CT; Cantley LC
    Am J Physiol; 1984 Dec; 247(6 Pt 2):F919-24. PubMed ID: 6095682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of specific endogenous ouabainlike substance from bovine adrenal.
    Inagami T; Tamura M
    Am J Med Sci; 1988 Apr; 295(4):400-5. PubMed ID: 2834953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of an endogenous digitalislike factor from human plasma for structural analysis.
    Ludens JH; Clark MA; DuCharme DW; Harris DW; Lutzke BS; Mandel F; Mathews WR; Sutter DM; Hamlyn JM
    Hypertension; 1991 Jun; 17(6 Pt 2):923-9. PubMed ID: 1646171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive inotropic effects of the endogenous Na+/K(+)-transporting ATPase inhibitor from the hypothalamus.
    Hallaq HA; Haupert GT
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10080-4. PubMed ID: 2557617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ouabainlike factor in Milan hypertensive rats.
    Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P
    Am J Physiol; 1992 Oct; 263(4 Pt 2):F739-48. PubMed ID: 1329560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of hypothalamic Na,K-ATPase inhibitor with isolated human peripheral blood mononuclear cells.
    Anner BM; Lacotte D; Anner RM; Moosmayer M
    Biosci Rep; 1994 Oct; 14(5):231-42. PubMed ID: 7772716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.